| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.038 | 0.8 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.051 | 0.8 |